The selection of mature B cells is critically dependent on the expression level of the co-receptor CD19

Immunology Letters

Volumn 160, Issue 2, 2014, Pages 113-119

  von Muenchow, Lilly ^a   Engdahl, Corinne ^a   Karjalainen, Klaus ^b   Rolink, Antonius G ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

B cell development; CD19; Nup98 HoxB4; Selection

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD19 ANTIGEN; HOMEODOMAIN PROTEIN; HOXB4 PROTEIN, MOUSE; NUCLEAR PORE COMPLEX PROTEIN 98; NUCLEOPORIN; PRE B CELL RECEPTOR; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BONE MARROW; CELL COMPARTMENTALIZATION; CELL IMMORTALIZATION; CELL MATURATION; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; MOUSE; NEGATIVE SELECTION; NONHUMAN; POSITIVE SELECTION; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PURIFYING SELECTION; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; ANIMAL; BONE MARROW CELL; CELL DIFFERENTIATION; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; IMMUNOPHENOTYPING; KNOCKOUT MOUSE; MALE; METABOLISM;

ANIMALS; ANTIGENS, CD19; BONE MARROW CELLS; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HOMEODOMAIN PROTEINS; IMMUNOPHENOTYPING; MALE; MICE; MICE, KNOCKOUT; NUCLEAR PORE COMPLEX PROTEINS; PRE-B CELL RECEPTORS; PRECURSOR CELLS, B-LYMPHOID; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84902381575     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.01.011     Document Type: Article

References (26)

1. Niiro H., Clark E.A. Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol 2002, 2:945-956.
2. Bradbury L.E., Kansas G.S., Levy S., Evans R.L., Tedder T.F. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J Immunol 1992, 149:2841-2850.
3. Matsumoto A.K., Kopicky-Burd J., Carter R.H., Tuveson D.A., Tedder T.F., Fearon D.T. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J Exp Med 1991, 173:55-64.
4. Carter R.H., Fearon D.T. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992, 256:105-107.
5. Tuveson D.A., Carter R.H., Soltoff S.P., Fearon D.T. CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 1993, 260:986-989.
6. Fujimoto M., Fujimoto Y., Poe J.C., Jansen P.J., Lowell C.A., DeFranco A.L., et al. CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification. Immunity 2000, 13:47-57.
7. Shivtiel S., Leider N., Sadeh O., Kraiem Z., Melamed D. Impaired light chain allelic exclusion and lack of positive selection in immature B cells expressing incompetent receptor deficient of CD19. J Immunol 2002, 168:5596-5604.
8. Keren Z., Diamant E., Ostrovsky O., Bengal E., Melamed D. Modification of ligand-independent B cell receptor tonic signals activates receptor editing in immature B lymphocytes. J Biol Chem 2004, 279:13418-13424.
9. Nadler L.M., Anderson K.C., Marti G., Bates M., Park E., Daley J.F., et al. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J Immunol 1983, 131:244-250.
10. Nadler L.M., Korsmeyer S.J., Anderson K.C., Boyd A.W., Slaughenhoupt B., Park E., et al. B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation. J Clin Invest 1984, 74:332-340.
11. Engel P., Zhou L.J., Ord D.C., Sato S., Koller B., Tedder T.F. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 1995, 3:39-50.
12. Rickert R.C., Rajewsky K., Roes J. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 1995, 376:352-355.
13. Zhou L.J., Smith H.M., Waldschmidt T.J., Schwarting R., Daley J., Tedder T.F. Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development. Mol Cell Biol 1994, 14:3884-3894.
14. Ruedl C., Khameneh H.J., Karjalainen K. Manipulation of immune system via immortal bone marrow stem cells. Int Immunol 2008, 20:1211-1218.
15. Shinkai Y., Rathbun G., Lam K.P., Oltz E.M., Stewart V., Mendelsohn M., et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992, 68:855-867.
16. Malissen M., Gillet A., Ardouin L., Bouvier G., Trucy J., Ferrier P., et al. Altered T cell development in mice with a targeted mutation of the CD3-epsilon gene. EMBO J 1995, 14:4641-4653.
17. Sauvageau G., Thorsteinsdottir U., Eaves C.J., Lawrence H.J., Largman C., Lansdorp P.M., et al. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev 1995, 9:1753-1765.
18. Alt F., Rosenberg N., Lewis S., Thomas E., Baltimore D. Organization and reorganization of immunoglobulin genes in A-MULV-transformed cells: rearrangement of heavy but not light chain genes. Cell 1981, 27:381-390.
19. Kinsella T.M., Nolan G.P. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum Gene Ther 1996, 7:1405-1413.
20. Rolink A.G., Melchers F., Palacios R. Monoclonal antibodies reactive with the mouse interleukin 5 receptor. J Exp Med 1989, 169:1693-1701.
21. Benard A., Ceredig R., Rolink A.G. Regulatory T cells control autoimmunity following syngeneic bone marrow transplantation. Eur J Immunol 2006, 36:2324-2335.
22. Bannish G., Fuentes-Panana E.M., Cambier J.C., Pear W.S., Monroe J.G. Ligand-independent signaling functions for the B lymphocyte antigen receptor and their role in positive selection during B lymphopoiesis. J Exp Med 2001, 194:1583-1596.
23. Gay D., Saunders T., Camper S., Weigert M. Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med 1993, 177:999-1008.
24. Tiegs S.L., Russell D.M., Nemazee D. Receptor editing in self-reactive bone marrow B cells. J Exp Med 1993, 177:1009-1020.
25. Kozmik Z., Wang S., Dorfler P., Adams B., Busslinger M. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol Cell Biol 1992, 12:2662-2672.
26. van Zelm M.C., Reisli I., van der Burg M., Castano D., van Noesel C.J., van Tol M.J., et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 2006, 354:1901-1912.